[go: up one dir, main page]

TN2014000342A1 - New pediatric uses of cabazitaxel - Google Patents

New pediatric uses of cabazitaxel

Info

Publication number
TN2014000342A1
TN2014000342A1 TNP2014000342A TN2014000342A TN2014000342A1 TN 2014000342 A1 TN2014000342 A1 TN 2014000342A1 TN P2014000342 A TNP2014000342 A TN P2014000342A TN 2014000342 A TN2014000342 A TN 2014000342A TN 2014000342 A1 TN2014000342 A1 TN 2014000342A1
Authority
TN
Tunisia
Prior art keywords
cabazitaxel
pediatric uses
new pediatric
new
solvate
Prior art date
Application number
TNP2014000342A
Other languages
English (en)
Inventor
S Sidhu Sukhvinder
Patricia Vrignaud
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/052518 external-priority patent/WO2013117683A1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of TN2014000342A1 publication Critical patent/TN2014000342A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TNP2014000342A 2012-10-30 2014-08-07 New pediatric uses of cabazitaxel TN2014000342A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306352 2012-10-30
PCT/EP2013/052518 WO2013117683A1 (fr) 2012-02-10 2013-02-08 Nouvelles utilisations pédiatriques du cabazitaxel

Publications (1)

Publication Number Publication Date
TN2014000342A1 true TN2014000342A1 (en) 2015-12-21

Family

ID=47137643

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2014000342A TN2014000342A1 (en) 2012-10-30 2014-08-07 New pediatric uses of cabazitaxel

Country Status (1)

Country Link
TN (1) TN2014000342A1 (fr)

Similar Documents

Publication Publication Date Title
PH12017502141A1 (en) Compounds and their methods of use
PH12014502169A1 (en) N-cyclylamides as nematicides
IN2015DN01156A (fr)
NZ700928A (en) Dna-pk inhibitors
IN2014DN09346A (fr)
MX2015002040A (es) Baricitinib deuterado.
IN2015DN00598A (fr)
MX2015007097A (es) Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer.
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
PH12015501088A1 (en) Dimeric compounds
GEP201706690B (en) Novel process for making compounds for use in treatment of cancer
GEP201706626B (en) Synthesis of (s)-nifuratel
TN2012000469A1 (en) Use of novel pan-cdk inhibitors for treating tumors
MX2016001641A (es) Ciclobutilcarboxamidas como nematicidas.
PH12015500399A1 (en) Azaindolines
NZ720106A (en) A process for the preparation of regadenoson
AU2016204389A1 (en) Kinase inhibitors for the treatment of cancer
MX2015014470A (es) Analogos de combretastatina.
MX365192B (es) Derivados de bendamustina y compuestos relacionados, y uso medico de los mismos para la terapia de cancer.
MX2016000487A (es) Piridina-2-carboxamidas como nematicidas.
EA033160B1 (ru) Соединения для лечения заболеваний, связанных с ишемией-реперфузией
MX2017014463A (es) Cabazitaxel y su uso para tratar cancer.
PH12015502703A1 (en) Pharmaceutical compositions
PH12014501794A1 (en) New pediatric uses of cabazitaxel
TN2014000342A1 (en) New pediatric uses of cabazitaxel